PARIS and FORT WORTH, Texas, April 5 /PRNewswire/ -- Galderma International S.A. today announced that Arthur Clapp, Vice President, Business Development at Galderma Laboratories, L.P., will present an overview of Galderma and the Company's biotechnology and pharmaceutical partnering initiatives at the upcoming BIO 2006 Annual International Convention which is being held at the McCormick Place Convention Center, Chicago, Ill., April 9-12, 2006. The presentation will take place in the conference Business Forum on Wednesday, April 12, 2006 at 9:00 a.m. central time. In addition to the Company presentation, Galderma will have five representatives participating in one-on-one partnering meetings in the BIO 2006 Business Forum.
The company's growing product portfolio includes treatment for major skin conditions -- acne, rosacea, fungal nail infections, psoriasis, non-melanoma skin cancer and photodamage, and hyperpigmentation disorders. Galderma is actively seeking to establish in-licensing or co-development partnerships with biotechnology and pharmaceutical companies.
Galderma's partnered products, programs and discovery technologies are supported by global product development capabilities and a world renowned sales force of over 900 representatives in more than 65 countries. Galderma has a history of successful transactions that have resulted in the creation of numerous commercialized prescription products including Metvix(R), Clobex(R), Clindagel(R), Loceryl(R), Tri-Luma(R), Silkis(R), and MetroGel(R)/Rozex(R).
Partnering Opportunities:
Galderma understands what it takes to build and nurture successful relationships. Galderma is interested in reviewing products that have a known mechanism of action with both profiled safety and some proof of concept in humans. Products can either be topical or systemic; small molecules or biologics; or even a medical device or delivery platform. Galderma's research teams are also looking for novel compound libraries, assays, in vivo models, and disease targets.
About Galderma:
Galderma is one of the world's leading specialty pharmaceutical companies, focused exclusively on research, development and marketing of dermatology products. The company deploys a worldwide network of 33 fully owned subsidiaries with products marketed in more than 70 countries. Galderma International S.A. is headquartered in Paris, France and Galderma Laboratories, L.P., the United States subsidiary of Galderma Pharma S.A., is headquartered in Fort Worth, Texas.
For partnering inquiries, please contact: Chris de Bruyne Arthur Clapp Galderma International S.A. Galderma Laboratories L.P. Paris, France Fort Worth, Texas +33-1-5886-4375 +1 (817) 961-5005
GaldermaCONTACT: Chris de Bruyne of Galderma International S.A., +33-1-5886-4375;or Arthur Clapp of Galderma Laboratories L.P., +1-817-961-5005
